Literature DB >> 19462316

Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification.

Ilknur Kozanoglu1, Can Boga, Hakan Ozdogu, Oktay Sozer, Erkan Maytalman, Ayse Canan Yazici, Feride Iffet Sahin.   

Abstract

BACKGROUND AIMS: Mesenchymal stromal cells (MSC) exhibit non-specific hematopoietic cell and/or stromal cell markers (e.g. CD73, CD105 and CD166) that have been used to identify MSC by flow cytometry. Because a neural glial antigen, NG2 (a progenitor cell marker in the central nervous system), is expressed by several tissue cells originating in the mesenchyme but not hematopoietic cells, it might be useful for isolating and identifying MSC. We investigated NG2 expression on culture-expanded MSC by flow cytometry.
METHODS: Human bone marrow (BM) samples taken from 12 donors were cultured for MSC to be used in up to nine serial passages. Using flow cytometry, the neural glial antigen NG2 and commonly used MSC markers CD73, CD105 and CD166, were analyzed on the surface of culture-expanded MSC. The multipotential differentiation of the MSC was examined by adipogenic and osteogenic induction.
RESULTS: The percentage of cells positive for NG2 was similar to the percentages of cells positive for CD73, CD105 and CD166 in all passages of BM samples. The mean fluorescent intensities of NG2 did not change with culture passage. The MSC was successfully differentiated into adipogenic and osteogenic lines. The cells showed no karyotypic abnormalities.
CONCLUSIONS: NG2 seems to be a promising marker for investigating the biology of MSC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19462316     DOI: 10.1080/14653240902923153

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  20 in total

Review 1.  CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.

Authors:  Matthew A Price; Leah E Colvin Wanshura; Jianbo Yang; Jennifer Carlson; Bo Xiang; Guiyuan Li; Soldano Ferrone; Arkadiusz Z Dudek; Eva A Turley; James B McCarthy
Journal:  Pigment Cell Melanoma Res       Date:  2011-12       Impact factor: 4.693

2.  Mesenchymal stromal cell characteristics vary depending on their origin.

Authors:  Heike Wegmeyer; Ann-Marie Bröske; Mathias Leddin; Karin Kuentzer; Anna Katharina Nisslbeck; Julia Hupfeld; Kornelius Wiechmann; Jennifer Kuhlen; Christoffer von Schwerin; Carsten Stein; Saskia Knothe; Jürgen Funk; Ralf Huss; Markus Neubauer
Journal:  Stem Cells Dev       Date:  2013-06-22       Impact factor: 3.272

3.  sdf1 Expression reveals a source of perivascular-derived mesenchymal stem cells in zebrafish.

Authors:  Troy C Lund; Xiaobai Patrinostro; Ashley C Kramer; Paul Stadem; Lee Ann Higgins; Todd W Markowski; Matt S Wroblewski; Diane S Lidke; Jakub Tolar; Bruce R Blazar
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

4.  NOTCH3 regulates stem-to-mural cell differentiation in infantile hemangioma.

Authors:  Andrew K Edwards; Kyle Glithero; Peter Grzesik; Alison A Kitajewski; Naikhoba Co Munabi; Krista Hardy; Qian Kun Tan; Michael Schonning; Thaned Kangsamaksin; Jan K Kitajewski; Carrie J Shawber; June K Wu
Journal:  JCI Insight       Date:  2017-11-02

5.  Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells.

Authors:  Katie C Russell; H Alan Tucker; Bruce A Bunnell; Michael Andreeff; Wendy Schober; Andrew S Gaynor; Karen L Strickler; Shuwen Lin; Michelle R Lacey; Kim C O'Connor
Journal:  Tissue Eng Part A       Date:  2013-05-30       Impact factor: 3.845

6.  Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model.

Authors:  Sakine Işık; Meral Karaman; Aysun Adan; Müge Kıray; Hüsnü Alper Bağrıyanık; Şule Çağlayan Sözmen; İlknur Kozanoğlu; Özkan Karaman; Yusuf Baran; Nevin Uzuner
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-05       Impact factor: 2.503

Review 7.  Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?

Authors:  Ann H Klopp; Anshul Gupta; Erika Spaeth; Michael Andreeff; Frank Marini
Journal:  Stem Cells       Date:  2011-01       Impact factor: 6.277

8.  Aberrant lymphatic endothelial progenitors in lymphatic malformation development.

Authors:  June K Wu; Christopher Kitajewski; Maia Reiley; Connie H Keung; Julie Monteagudo; John P Andrews; Peter Liou; Arul Thirumoorthi; Alvin Wong; Jessica J Kandel; Carrie J Shawber
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

Review 9.  Theranostic impact of NG2/CSPG4 proteoglycan in cancer.

Authors:  Pier Andrea Nicolosi; Alice Dallatomasina; Roberto Perris
Journal:  Theranostics       Date:  2015-02-15       Impact factor: 11.556

Review 10.  The Role of NG2 Proteoglycan in Glioma.

Authors:  Sridevi Yadavilli; Eugene I Hwang; Roger J Packer; Javad Nazarian
Journal:  Transl Oncol       Date:  2016-02       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.